The 4G/4G polymorphism of PAI-1, associated with high plasma level of PAI-1 activity, is a risk factor for coronary heart diseases and venous thrombosis, especially in patients with other genetic thrombophilia mutations. This evidence concerns the gene SERPINE1 and thrombophilia.